9-27296694-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020641.3(EQTN):c.121G>A(p.Glu41Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000249 in 1,608,830 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020641.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EQTN | NM_020641.3 | c.121G>A | p.Glu41Lys | missense_variant | 2/8 | ENST00000380032.8 | |
EQTN | NM_001161585.2 | c.121G>A | p.Glu41Lys | missense_variant | 2/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EQTN | ENST00000380032.8 | c.121G>A | p.Glu41Lys | missense_variant | 2/8 | 1 | NM_020641.3 | P1 | |
EQTN | ENST00000537675.5 | c.121G>A | p.Glu41Lys | missense_variant | 2/7 | 1 | |||
EQTN | ENST00000380031.2 | c.121G>A | p.Glu41Lys | missense_variant | 2/4 | 1 | |||
EQTN | ENST00000484994.1 | n.47G>A | non_coding_transcript_exon_variant | 1/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152072Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 248152Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134046
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1456758Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 724706
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152072Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74282
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 26, 2024 | The c.121G>A (p.E41K) alteration is located in exon 2 (coding exon 2) of the EQTN gene. This alteration results from a G to A substitution at nucleotide position 121, causing the glutamic acid (E) at amino acid position 41 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at